A 68-year-old White woman with a history of severe primary open-angle glaucoma was referred for an evaluation. Her BCVA was 20/20 OU, and her IOP measured 14 mm Hg OU with Goldmann applanation tonometry. Read more from this editorial here:

🔬 From day one, physicians are taught to "do no harm"—prioritizing medical management before surgery. But with SLT, the glaucoma treatment paradigm is shifting. Read more from Catherine Johnson, MD, MPH, & Barbara Wirostko, MD, FARVO: #Glaucoma

Drs. Gurney and Lee make a case for considering TSCPC earlier in glaucoma treatment and reviewing proper technique and indications for max effectiveness and minimal complications.

Retrospective cohort study: Can deep learning predict rapid visual field worsening? Researchers evaluated 4,536 eyes from 2,962 glaucoma patients using 8 DLMs trained on clinical data (age, sex, BCVA, IOP), OCT & VFs. More by Drs. Oatts & Han:

In this video, Dr. Richman demonstrates a sideways sweeping motion to break scarring in the angle. He also addresses synechiae at the pupil and opens Schlemm canal.

The first International Glaucoma Symposium will be held by Heidelberg Engineering in conjunction with Mainz University on February 1, 2025:

Continue watching here:

Bausch + Lomb announced two seperate deals to acquire early- and mid-stage therapeutic assets. First, B+L, through an affiliate, acquired Whitecap Biosciences LLC, which is currently developing two therapies for potential use in glaucoma and GA:

Start the year strong with the latest issue of GT: "Drug Delivery – New Takes on a Longtime Challenge in Care." Explore it now at

👁️ January is National Glaucoma Awareness Month! Glaucoma is a leading cause of vision loss, but early detection saves sight. Spread awareness, share knowledge, & prioritize eye health. 💡 Get screened. Protect your vision.

Drs. Singh, Provencher, and Shafer review a real case in which they discuss patient risk factors and treatment goals. Later, they find out how colleagues would manage the case, based on results of a social media poll of GT’s audience:

As part of January’s National Glaucoma Awareness Month, the non-profit Prevent Blindness is offering free educational resources to patients, care partners, and professionals:

University of Connecticut scientists have published a report in the September issue of Experimental Neurology, showing injured optic nerves can regrow towards the brain if treated properly:

What is the impact of benzalkonium chloride on the long-term health of the eye? According to Jason Bacharach, MD, (of @northbayeye) there are implications beyond just the impact on the ocular surface:

In this article commemorating 75 years of innovation at #AbbVie, learn more about the company’s investment in R&D of different sustained-release platforms and medications, and surgical treatments that may help reduce patients’ reliance on medications. #ad

I. Paul Singh, MD, shares this teaching video to help other surgeons understand how to address the nasal trabecular meshwork using the OMNI Surgical System (Sight Sciences). Financial Disclosure: Consultant (Sight Sciences):

RT @eyewireplus: Bausch + Lomb announced that an affiliate has acquired Elios Vision, developer of the ELIOS procedure, a minimally invasiv…

Dr. I. Paul Singh discusses safety and efficacy, and his own clinical experience with the MINIject supraciliary MIGS device: MINIject is an investigational device in the US and not for sale.

The collaboration will explore aqueous outflow dynamics of ViaLase’s ViaLase laser procedure, utilizing Moran’s iPerfusion technology: